Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Clinical Pharmacology and Therapeutics
|
May 6, 2025
Gut Microbiota in Patients with Tuberculosis Associated with Different Drug Exposures of Antituberculosis Drugs
Yue Zhu, Qiao Liu, Jan-Willem Alffenaar, et al.
Open Forum Infectious Diseases
|
October 9, 2025
Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis
Andrea Llamas-Lopez, James A Seddon, Felicia C Chow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 24, 2024
Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China
Yue Zhu, Lina Davies Forsman, Cheng Chen, et al.
BMJ Open
|
April 29, 2021
Protocol for establishing an Adaptive Diseases control Expert Programme in Tanzania (ADEPT) for integrating care of communicable and non-communicable diseases using tuberculosis and diabetes as a case study
Stellah G Mpagama, Kaushik Ramaiya, Troels Lillebæk, et al.
International Journal of Antimicrobial Agents
|
September 28, 2020
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices
Sahand Imani, Jan-Willem Alffenaar, Menino O Cotta, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2020
Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients
Anne-Grete Märtson, Kim C M van der Elst, Anette Veringa, et al.
The Journal of Infection
|
July 8, 2026
Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic review
Gloria Sukali, Motswedi Anderson, Khadija Said Mohammed, et al.
Pathogens (Basel, Switzerland)
|
December 31, 2025
Association of Antimicrobial Susceptibility with Treatment Response in <i>Mycobacterium avium complex</i> Pulmonary Disease
Xuejiao Luo, Yuhang Chen, Lina Davies Forsman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 4, 2024
Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment
Sainan Wang, Lina Davies Forsman, Chunhua Xu, et al.
British Journal of Clinical Pharmacology
|
July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementation
Indy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Clinical Pharmacology and Therapeutics
|
May 6, 2025
Gut Microbiota in Patients with Tuberculosis Associated with Different Drug Exposures of Antituberculosis Drugs
Yue Zhu, Qiao Liu, Jan-Willem Alffenaar, et al.
Open Forum Infectious Diseases
|
October 9, 2025
Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis
Andrea Llamas-Lopez, James A Seddon, Felicia C Chow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 24, 2024
Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China
Yue Zhu, Lina Davies Forsman, Cheng Chen, et al.
BMJ Open
|
April 29, 2021
Protocol for establishing an Adaptive Diseases control Expert Programme in Tanzania (ADEPT) for integrating care of communicable and non-communicable diseases using tuberculosis and diabetes as a case study
Stellah G Mpagama, Kaushik Ramaiya, Troels Lillebæk, et al.
International Journal of Antimicrobial Agents
|
September 28, 2020
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices
Sahand Imani, Jan-Willem Alffenaar, Menino O Cotta, et al.
Antimicrobial Agents and Chemotherapy
|
July 15, 2020
Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients
Anne-Grete Märtson, Kim C M van der Elst, Anette Veringa, et al.
The Journal of Infection
|
July 8, 2026
Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic review
Gloria Sukali, Motswedi Anderson, Khadija Said Mohammed, et al.
Pathogens (Basel, Switzerland)
|
December 31, 2025
Association of Antimicrobial Susceptibility with Treatment Response in <i>Mycobacterium avium complex</i> Pulmonary Disease
Xuejiao Luo, Yuhang Chen, Lina Davies Forsman, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 4, 2024
Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment
Sainan Wang, Lina Davies Forsman, Chunhua Xu, et al.
British Journal of Clinical Pharmacology
|
July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementation
Indy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
Page
of 10